Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 5, 2021 - Issue 2
134
Views
1
CrossRef citations to date
0
Altmetric
Review Article - Assessing the Heart Team

Teamwork and Speed Bumps

, MD, , MD & , MD
Pages 158-162 | Received 23 Jul 2020, Accepted 18 Dec 2020, Published online: 19 Feb 2021
 

ABSTRACT

Heart Teams have come to occupy a prominent place in modern cardiovascular disease. While the concept is intuitively obvious - bringing together specialties of diverse backgrounds to focus on care of the individual patient - they have been harder to actually implement in clinical practice and it has been difficult to define metrics of success. One documented metric has been the design, implementation, and end result of randomized clinical trials that were conducted with co-investigators of both interventional cardiology and cardiovascular surgery which resulted in pivotal presentations of outcomes in specific patient groups. This metric, however, has come under scrutiny because of trial performance, conclusions, and implications for practice. The resulting controversies should not result in retreat from the concept of the Heart Team which should be at the heart of optimizing care for individual patients based upon scientific evidence and expert consensus on the issues of optimal cardiovascular care. The widespread use of telemedicine can play a major role in enhancing decision making by the Heart Team.

Abbreviations: IC: Interventional Cardiology; CVS: Cardiovascular Surgery; CABG: Coronary artery bypass grafting; PCI: Percutaneous coronary intervention; CAD: Coronary artery disease; TAVR: Transcatheter aortic valve replacement; SAVR: Surgical aortic valve replacement; RCTs: Randomized clinical trials; CMS: Centers for Medicare and Medicaid Services; FDA: Food and Drug Administration

Disclosure statement

Dr. Holmes has nothing to disclose.

Dr. Mack is a Co-PI of Partner trial of Edwards Lifesciences, CO-PI of COAPT trial of Abbott, and study chair of Apollo trial of Medtronic.

Dr. O’Gara is on the Executive Committee of the Medtronic Apollo TMVR Trial and on the Executive Committee of Edwards Lifesciences, EARLY TAVR Trial.

Additional information

Funding

The authors report no funding in support of this paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.